𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1234 POSTER A First in Man Phase 1 Study of JNJ-26481585, a Novel Oral Histone Deacetylase Inhibitor (HDACi) in Advanced Cancer Patients -Evidence of Target Modulation, Antitumour Activity and Additional Safety Data in an Expanded Patient Cohort

✍ Scribed by A. Omlin; B. Venugopal; R. Kristeleit; K. Shah; N. Fourneau; P. Hellemans; J. de Bono; R. Plummer; U. Banerji; J. Evans


Book ID
117661340
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
61 KB
Volume
47
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.